Fate Therapeutics Reports First Quarter 2014 Financial Results

Go back to Fate Therapeutics Reports First Quarter 2014 Financial Results
FATE THERAPEUTICS (NASDAQ: FATE) Delayed: 2.78 +0.05 (1.83%)
Previous Close $2.73    52 Week High $4.76 
Open $2.66    52 Week Low $1.46 
Day High $2.94    P/E N/A 
Day Low $2.60    EPS $-1.91 
Volume 1,692,629